IRIS
RUSSO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.324
EU - Europa 2.716
AS - Asia 2.561
SA - Sud America 548
AF - Africa 466
Continente sconosciuto - Info sul continente non disponibili 253
OC - Oceania 26
AN - Antartide 1
Totale 10.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.165
SG - Singapore 1.186
RU - Federazione Russa 901
IT - Italia 785
CN - Cina 714
BR - Brasile 441
CI - Costa d'Avorio 264
IE - Irlanda 257
VN - Vietnam 217
DE - Germania 153
KR - Corea 143
FR - Francia 141
CA - Canada 111
FI - Finlandia 88
UA - Ucraina 75
GB - Regno Unito 65
BD - Bangladesh 64
NG - Nigeria 64
AT - Austria 49
NL - Olanda 49
SN - Senegal 42
TR - Turchia 41
AR - Argentina 36
IN - India 34
KE - Kenya 33
SE - Svezia 31
ZA - Sudafrica 24
AU - Australia 21
PL - Polonia 20
BE - Belgio 18
CZ - Repubblica Ceca 18
VE - Venezuela 18
PK - Pakistan 17
JP - Giappone 16
IQ - Iraq 15
MX - Messico 15
BJ - Benin 14
CO - Colombia 14
EC - Ecuador 14
HK - Hong Kong 14
ID - Indonesia 13
IR - Iran 12
UZ - Uzbekistan 11
ES - Italia 10
PT - Portogallo 9
CH - Svizzera 8
GR - Grecia 8
JM - Giamaica 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
TW - Taiwan 7
CR - Costa Rica 6
LT - Lituania 6
TN - Tunisia 6
BG - Bulgaria 5
EG - Egitto 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
MA - Marocco 4
SV - El Salvador 4
UY - Uruguay 4
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
HR - Croazia 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AL - Albania 1
AQ - Antartide 1
BM - Bermuda 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
Totale 10.638
Salva come PNG Salva come JPEG
Città #
Singapore 736
Dallas 690
Santa Clara 547
Chandler 435
Moscow 392
San Jose 320
Abidjan 264
Dublin 246
Ashburn 214
Chicago 186
Catania 181
Hefei 172
Seoul 142
Houston 116
Beijing 114
Boardman 105
Los Angeles 101
Lauterbourg 78
Ho Chi Minh City 71
Jacksonville 69
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Council Bluffs 57
Andover 55
Hanoi 52
Helsinki 45
New York 44
Rome 43
Dakar 42
Nanjing 39
Lappeenranta 38
Des Moines 34
São Paulo 32
Toronto 32
Vienna 31
Abuja 28
Bremen 28
Buffalo 28
Lagos 26
Wilmington 24
Montreal 23
Munich 22
Ottawa 20
Pozzallo 19
Amsterdam 18
Dong Ket 18
Falls Church 18
Kayseri 18
Warsaw 18
Milan 17
Shanghai 17
Brno 16
Brussels 16
Columbus 16
Denver 16
Acireale 15
San Giovanni la Punta 15
The Dalles 15
Atlanta 14
Cotonou 14
Nanchang 14
Rio de Janeiro 14
Hong Kong 13
Messina 13
Naples 13
Saint Petersburg 13
Turin 13
Brooklyn 12
Chennai 12
Johannesburg 12
Orem 12
Poplar 12
Tokyo 12
Belo Horizonte 11
Boston 11
Mascalucia 11
Melbourne 11
Nairobi 11
Palermo 11
Phoenix 11
Salvador 11
Seattle 11
Florence 10
Grafing 10
Haiphong 10
Port Harcourt 10
Stockholm 10
Tianjin 10
Avola 9
Da Nang 9
Pedara 9
Philadelphia 9
Tehran 9
Campinas 8
Cape Town 8
Charlotte 8
London 8
Redondo Beach 8
Totale 6.859
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 323
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 198
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 197
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 191
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 181
Computational modelling in melanoma for novel drug discovery 180
Agent based modeling of the immune system: NetLogo, a promising framework 172
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 172
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 171
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 163
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 163
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 161
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 160
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 160
Boosting multiple sclerosis lesion segmentation through attention mechanism 158
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 156
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 156
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 151
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 150
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 148
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 144
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 141
In silico clinical trials: concepts and early adoptions 140
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 140
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 134
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 133
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 132
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 131
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 130
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 130
In silico design of recombinant multi-epitope vaccine against influenza A virus 125
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 123
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 122
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 122
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 119
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 119
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 118
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 116
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 115
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 115
Computational models to predict disease course and treatment response in multiple sclerosis 114
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 106
Credibility of In Silico Trial Technologies - A Theoretical Framing 106
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 105
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 104
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 103
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 103
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 103
Toward computational modelling on immune system function 103
PETAL: A Python tool for deep analysis of biological pathways 103
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 102
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 98
Modeling biology spanning different scales: An open challenge 97
Introducing scale factor adjustments on agent-based simulations of the immune system 97
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 96
How can we accelerate COVID-19 vaccine discovery? 96
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 95
Generation of digital patients for the simulation of tuberculosis with UISS-TB 93
Text mining and word embedding for classification of decision making variables in breast cancer surgery 91
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 90
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 89
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 89
The combination of artificial intelligence and systems biology for intelligent vaccine design 89
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 87
Computational immunogenetics 86
Computational modelling approaches to vaccinology 84
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 83
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 83
A Comparative Evaluation of Diffusion Based Networks for Multiple Sclerosis Lesion Segmentation 82
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 82
Modeling and Simulation of anakinra effects on severe COVID19 Patients 80
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 77
Quality by design tools reducing the gap from bench to bedside for nanomedicine 77
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 76
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 75
A Head-to-Head Evaluation of a Novel Universal Influenza Vaccine Against Current Formulation: Implications for Future Immunization Strategies 74
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 73
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 73
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 72
Generation of digital patients for the simulation of tuberculosis with UISS-TB 72
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 72
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 72
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 71
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 70
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 69
Model Credibility 67
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 65
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 65
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 64
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 62
Evaluation of word embedding models to extract and predict surgical data in breast cancer 60
Model Development 57
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 56
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling 53
Toward computational modelling on immune system function 53
Breaking the Cycle: Advancements in Universal Influenza Vaccine Design 50
An integrated in vitro and in silico testing strategy applied to PFAS inhibition of antibody production to define a tolerable daily intake 50
Computational modeling of ATM signaling: a predictive framework for drug repurposing in ataxia-telangiectasia 29
A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and in silico gene expression profiling 28
In-silico epitope-based vaccines design: progress, challenges and the road ahead 25
Totale 10.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022431 0 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/20265.203 282 345 847 307 652 1.145 470 124 326 361 203 141
2026/2027224 167 57 0 0 0 0 0 0 0 0 0 0
Totale 10.895